13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001569064
Total reported value
$5.5B
$5.5B
92 檔
20.5%
During the Q3 2025 filing period, Montanova Capital, LLC (CIK: 0001569064) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $5.5B across 92 reported positions.
Montanova Capital, LLC executed strategic sector rebalancing during Q3 2025, establishing 13 new positions while fully exiting 21 holdings and trimming 18 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 13.64% | +7.16% | +14.29% | |
| 2 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 5.06% | -1.46% | -9.17% | |
| 3 | BNTC | Benitec Biopharma Inc | Stock-Other | 3.55% | -0.31% | — | |
| 4 | META | Meta Platforms Inc-class A | Stock-Comm Services | 3.21% | -0.67% | +0.66% | |
| 5 | LEGN | Legend Biotech Corp-adr | Stock-Other | 3.19% | +0.23% | +1.17% | |
| 6 | ETNBGBP | 89bio Inc | Stock-Other | 3.12% | — | -41.73% | |
| 7 | ✓ | Immatics NV | Stock-Other | 2.62% | -0.74% | — | |
| 8 | KO | Coca-cola Co/the | Stock-Consumer Staples | 2.47% | — | +17.99% | |
| 9 | GE | General Electric | Stock-Industrials | 2.39% | -0.13% | — | |
| 10 | NVDA | Nvidia CORP | Stock-Tech | 2.31% | +0.08% | -51.63% | |
| 11 | EYPT | Eyepoint Inc | Stock-Other | 2.26% | -0.56% | -8.99% | |
| 12 | BHVN | Biohaven Ltd. | Stock-Other | 2.16% | +0.58% | — | |
| 13 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 2.07% | -0.97% | +22.22% | |
| 14 | HD | Home Depot Inc | Stock-Consumer Disc | 2.05% | -0.40% | +50.94% | |
| 15 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 1.98% | +0.08% | -7.72% | |
| 16 | KURA | Kura Oncology Inc | Stock-Other | 1.84% | -0.06% | — | |
| 17 | FERG | Ferguson Enterprises Inc | Stock-Industrials | 1.76% | -0.19% | +61.48% | |
| 18 | AVBP | Arrivent Biopharma Inc | Stock-Other | 1.75% | +0.28% | +8.52% | |
| 19 | KDP | Keurig Dr Pepper Inc | Stock-Consumer Staples | 1.68% | — | — | |
| 20 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 1.67% | -3.62% | EXIT | |
| 21 | AMD | Advanced Micro Devices | Stock-Tech | 1.65% | +1.39% | — | |
| 22 | ORCL | Oracle CORP | Stock-Tech | 1.63% | — | -1.91% | |
| 23 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.55% | — | -11.37% | |
| 24 | BAC | Bank Of America CORP | Stock-Financials | 1.53% | -0.79% | +25.14% | |
| 25 | 4XC1 | Kalvista Pharmaceuticals Inc | Stock-Other | 1.49% | -2.45% | EXIT | |
| 26 | APO | Apollo Global Management Inc | Stock-Financials | 1.47% | -0.27% | +0.65% | |
| 27 | MSFT | Microsoft CORP | Stock-Tech | 1.45% | -0.02% | +10.75% | |
| 28 | PVLA | Palvella Therapeutics Inc | Stock-Other | 1.32% | -0.50% | +15.11% | |
| 29 | COF | Capital One Financial CORP | Stock-Financials | 1.30% | -0.19% | +22.98% | |
| 30 | DHR | Danaher CORP | Stock-Healthcare | 1.30% | -0.09% | +46.42% | |
| 31 | RCUS | Arcus Biosciences Inc | Stock-Other | 1.28% | -0.09% | — | |
| 32 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 1.28% | — | — | |
| 33 | FULC | Fulcrum Therapeutics Inc | Stock-Other | 1.27% | -1.04% | +5.86% | |
| 34 | CMPX | Compass Therapeutics Inc | Stock-Other | 1.26% | -1.37% | +97.23% | |
| 35 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 1.23% | -0.46% | -15.17% | |
| 36 | TSLA | Tesla Inc | Stock-Consumer Disc | 1.04% | -0.05% | EXIT | |
| 37 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.88% | -0.09% | — | |
| 38 | MSOS | Advisorshares Pure US Cann | ETF-Other | 0.88% | +0.08% | — | |
| 39 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.85% | -0.21% | +41.50% | |
| 40 | RNAGBP | Avidity Biosciences Inc | Stock-Other | 0.84% | — | — | |
| 41 | ERAS | Erasca Inc | Stock-Other | 0.81% | -1.42% | EXIT | |
| 42 | INSM | Insmed Inc | Stock-Healthcare | 0.80% | — | -8.79% | |
| 43 | PROK | Prokidney CORP | Stock-Other | 0.76% | -0.10% | — | |
| 44 | CRM | Salesforce Inc | Stock-Tech | 0.76% | — | — | |
| 45 | DKS | Dick's Sporting Goods Inc | Stock-Consumer Disc | 0.73% | +0.63% | NEW | |
| 46 | AURA | Aura Biosciences Inc | Stock-Other | 0.69% | +0.19% | — | |
| 47 | GLUE | Monte Rosa Therapeutics Inc | Stock-Other | 0.64% | -0.21% | — | |
| 48 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.63% | -0.11% | — | |
| 49 | ✓ | Zura Bio LTD | Stock-Other | 0.61% | -0.36% | +12.59% | |
| 50 | BIIB | Biogen Inc | Stock-Healthcare | 0.60% | — | +10.73% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | +5.3% | +14.29% | Add |
| 2 | KO | Coca-cola Co/the | +1.4% | +17.99% | Add |
| 3 | DHR | Danaher CORP | +1.2% | +46.42% | Add |
| 4 | ✓ | Immatics NV | +1.1% | — | Add |
| 5 | MLYS | Mineralys Therapeutics Inc | +1.1% | +22.22% | Add |
| 6 | FERG | Ferguson Enterprises Inc | +1% | +61.48% | Add |
| 7 | GE | General Electric | +0.9% | — | Add |
| 8 | NVDA | Nvidia CORP | +0.9% | -51.63% | Add |
| 9 | EYPT | Eyepoint Inc | +0.9% | -8.99% | Trim |
| 10 | FULC | Fulcrum Therapeutics Inc | +0.7% | +5.86% | Add |
| 11 | HD | Home Depot Inc | +0.7% | +50.94% | Add |
| 12 | PVLA | Palvella Therapeutics Inc | +0.6% | +15.11% | Add |
| 13 | RCUS | Arcus Biosciences Inc | +0.5% | — | Add |
| 14 | ORCL | Oracle CORP | +0.5% | -1.91% | Unchanged |
| 15 | ✓ | Zura Bio LTD | +0.4% | +12.59% | Add |
| 16 | GLUE | Monte Rosa Therapeutics Inc | +0.4% | — | Add |
| 17 | BAC | Bank Of America CORP | +0.4% | +25.14% | Add |
| 18 | APLSUSD | Apellis Pharmaceuticals Inc | +0.3% | — | Add |
| 19 | UNH | Unitedhealth Group Inc | +0.3% | +41.50% | Add |
| 20 | ERAS | Erasca Inc | +0.2% | — | Add |
| 21 | AVBP | Arrivent Biopharma Inc | +0.2% | +8.52% | Add |
| 22 | AMD | Advanced Micro Devices | +0.1% | — | Trim |
| 23 | AURA | Aura Biosciences Inc | +0.1% | — | Add |
| 24 | CTNM | Contineum Therapeutics Inc-a | +0.1% | — | Unchanged |
| 25 | ELAN | Elanco Animal Health Inc | 0% | — | Unchanged |
| 26 | KURA | Kura Oncology Inc | 0% | — | Add |
| 27 | TMO | Thermo Fisher Scientific Inc | 0% | +69.62% | Add |
| 28 | IONS | Ionis Pharmaceuticals Inc | 0% | — | Unchanged |
| 29 | LKFT | Lakefront Biotherapeutic-adr | — | — | Unchanged |
| 30 | RMD | Resmed Inc | — | — | Unchanged |
| 31 | A | Agilent Technologies Inc | — | — | Unchanged |
| 32 | PACS | Pacs Group Inc | — | — | Unchanged |
| 33 | ZBH | Zimmer Biomet Holdings Inc | — | — | Unchanged |
| 34 | STE | STERIS plc | — | — | Unchanged |
| 35 | BIIB | Biogen Inc | 0% | +10.73% | Add |
| 36 | MRK | Merck & Co. Inc. | 0% | — | Add |
| 37 | HCA | Hca Healthcare Inc | 0% | — | Unchanged |
| 38 | NTRA | Natera Inc | 0% | — | Unchanged |
| 39 | MCK | Mckesson CORP | 0% | — | Unchanged |
| 40 | EW | Edwards Lifesciences CORP | 0% | — | Unchanged |
| 41 | VLTO | Veralto CORP | 0% | — | Unchanged |
| 42 | EXK | Exact Sciences CORP | 0% | — | Unchanged |
| 43 | AVTR | Avantor Inc | 0% | — | Unchanged |
| 44 | WAT | Waters CORP | 0% | — | Unchanged |
| 45 | MDT | Medtronic plc | 0% | — | Unchanged |
| 46 | IQV | Iqvia Holdings Inc | 0% | — | Unchanged |
| 47 | SYK | Stryker CORP | 0% | — | Unchanged |
| 48 | GS | Goldman Sachs Group Inc | 0% | — | Trim |
| 49 | IFRX | InflaRx N.V. | 0% | — | Unchanged |
| 50 | SRPT | Sarepta Therapeutics Inc | 0% | — | Unchanged |
According to official SEC Form 13F filings, Montanova Capital, LLC reported a total U.S. public equity portfolio value of $5.5B across 92 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, ARQT, BNTC) accounted for 20.5% of total reported equity market value during Q3 2025.
Top New Position Initiated
KDP
市值: $65.6M
Top Position Liquidated / Trimmed
ITCIEUR
前期市值: $92.5M
During Q3 2025, Montanova Capital, LLC's top holdings by market value included SPY (13.6%)、ARQT (5.1%)、BNTC (3.5%). The largest single position, SPY, represented 13.6% of total portfolio value.
In Q3 2025, Montanova Capital, LLC made 81 total portfolio adjustments, initiating 13 new buys, adding to 29 positions, trimming 18 holdings, and fully liquidating 21 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.